A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.

Autor: Rossi BM; Hospital Sirio Libanes, Sao Paulo, Brazil., Palmero EI; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil., López-Kostner F; Laboratorio de Oncología y Genética Molecular, Clínica Los Condes, Santiago, Chile., Sarroca C; Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay., Vaccaro CA; Hereditary Cancer Program (PROCANHE), Hospital Italiano, Buenos Aires, Argentina., Spirandelli F; Servicio de Coloproctologia y Asesoria Genetica en Cancer, Hospital Español de Rosario, Rosario, Argentina., Ashton-Prolla P; Departamento de Genética da Universidade Federal do Rio Grande do Sul (UFRGS) e Serviço de Genética Médica do Hospital de Clinicas de Porto Alegre (HCPA) & Rede Brasileira de Câncer Hereditário, Porto Alegre, Rio Grande Do Sul, Brazil., Rodriguez Y; Clinica del Country, Bogota, Colombia., de Campos Reis Galvão H; Oncogenetics Department, Barretos Cancer Hospital, Barretos, SP, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital & Life and Health Sciences Research Institute (ICVS), Health Sciences School, University of Minho, Braga, Portugal.; ICVS/3B's-PT Government Associate Laboratory, Braga, Guimarães, Portugal., Escremim de Paula A; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil., Capochin Romagnolo LG; Oncogenetics Department, Barretos Cancer Hospital, Barretos, SP, Brazil., Alvarez K; Laboratorio de Oncología y Genética Molecular, Clínica Los Condes, Santiago, Chile., Della Valle A; Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay., Neffa F; Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay., Kalfayan PG; Hereditary Cancer Program (PROCANHE), Hospital Italiano, Buenos Aires, Argentina., Spirandelli E; Servicio de Coloproctologia y Asesoria Genetica en Cancer, Hospital Español de Rosario, Rosario, Argentina., Chialina S; Servicio de Coloproctologia y Asesoria Genetica en Cancer, Hospital Español de Rosario, Rosario, Argentina., Gutiérrez Angulo M; Centro Universitario de los Altos, Universidad de Guadalajara, Jalisco, Mexico., Castro-Mujica MDC; Equipo Funcional de Genética y Biologia Molecular, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Sanchez de Monte J; Instituto Nacional de Cancerologia de México, México City, Mexico., Quispe R; Laboratorio de Genética Molecular del Instituto de Servicios de Laboratorio de Diagnóstico e Investigación en Salud (SELADIS), La Paz, Bolivia., da Silva SD; Lady Davis Institute for Medical Research and Segal Cancer Center, Jewish General Hospital, Montreal, Quebec, Canada.; Department of Otolaryngology-Head and Neck Surgery, McGill University, Montreal, Quebec, Canada., Rossi NT; Hospital Privado Universitario de Cordoba, Cordoba, Argentina., Barletta-Carrillo C; Equipo Funcional de Genética y Biologia Molecular, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Revollo S; Laboratorio de Genética Molecular del Instituto de Servicios de Laboratorio de Diagnóstico e Investigación en Salud (SELADIS), La Paz, Bolivia., Taborga X; Laboratorio de Genética Molecular del Instituto de Servicios de Laboratorio de Diagnóstico e Investigación en Salud (SELADIS), La Paz, Bolivia., Morillas LL; Centro de Enfermedades Neoplasicas ONCOVIDA, La Paz, Bolivia., Tubeuf H; Inserm-U1079-IRIB, UNIROUEN, Normandie Univ, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.; Interactive Biosoftware, Rouen, France., Monteiro-Santos EM; Hospital Sirio Libanes, Sao Paulo, Brazil., Piñero TA; Instituto de Ciencias Basicas y Medicina Experimental (ICBME), Hospital Italiano, Buenos Aires, Argentina., Dominguez-Barrera C; Department of Preventive Medicine, Faculty of Medicine, Universidad Nacional Mayor de San Marcos (UNMSM), Lima, Peru., Wernhoff P; Department of Clinical Molecular Biology (EpiGen), Akershus University Hospital, Lørenskog, Norway., Martins A; Inserm-U1079-IRIB, UNIROUEN, Normandie Univ, Normandy Centre for Genomic and Personalized Medicine, Rouen, France., Hovig E; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Møller P; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.; Department of Human Medicine, Universität Witten/Herdecke, Witten, Germany., Dominguez-Valentin M; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. mev.dominguez.valentin@rr-research.no.

Publikováno v: BMC cancer [BMC Cancer] 2017 Sep 05; Vol. 17 (1), pp. 623. Date of Electronic Publication: 2017 Sep 05.